Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysyl-tRNA synthetase (LysRS) is an essential enzyme that catalyzes the attachment of the amino acid lysine to its corresponding tRNA (tRNALys), a critical step in protein synthesis. This process, known as aminoacylation, ensures that lysine is correctly incorporated into proteins during translation. It is a therapeutic target for antibiotic development against pathogens like Mycobacterium tuberculosis.
Inhibition of lysyl-tRNA synthetase
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysyl-tRNA synthetase (LysRS).